Hematide, a novel peptide-based erythropoiesis-stimulating agent for the treatment of anemia.

Hematide is a synthetic peptide-based erythropoiesis-stimulating agent that is being developed by Affymax Inc and Takeda Pharmaceutical Co Ltd. Hematide is undergoing phase III clinical trials for anemia.